3'-(4-morpholinyl)-3'-deaminodaunorubicin has been researched along with Leukemia P388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, EM; Fujiwara, AN; Mosher, CW; Wu, HY | 1 |
1 other study(ies) available for 3'-(4-morpholinyl)-3'-deaminodaunorubicin and Leukemia P388
Article | Year |
---|---|
Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1982 |